Screener
Immunovant, Inc. IMVT Total debt
Discontinued — last reported Q4 '26
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $72K.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026. Open the filing →
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
FAQ
- What is Immunovant, Inc.'s total debt?
- Immunovant, Inc. (IMVT) reported total debt of $72K in Q1 2026.
- How has Immunovant, Inc.'s total debt changed year-over-year?
- Immunovant, Inc.'s total debt decreased by 26.5% year-over-year, from $98K to $72K.
- What is the long-term trend for Immunovant, Inc.'s total debt?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s total debt has grown at a -53.8% compound annual growth rate (CAGR), from $3.42M to $72K.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Immunovant, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude